Burkhart Erin reported tax withholding involving 768 shares of GILEAD SCIENCES, INC. at $152.67 for −$117k on Sep 22, 2026

Tax withholding
Form 4 code F. Payment of an exercise price or tax liability by delivering or withholding securities in a Rule 16b-3 transaction.
SVP, Controllership
SVP, Controllership
Filed Sep 23, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$117,250.56Shares × reported price
Shares traded
768Common Stock
Price per share
$152.67Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
1,455Direct
Trade date
Sep 22, 2026Tax withholding
Filed
Sep 23, 2026, 4:17 PM ET1-day reporting delay
Accession
0001927648-26-000005Code F · Transaction 228300
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 22, 2026Option exercise2,223——Trade 228299
Sep 22, 2026Option exercise2,223——Trade 228301
3 transaction rows in this filing. Joint filers share the same rows.

GILD price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
GILD · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −3.5%1w ago −3.3%1d ago −0.5%
Returns since7d −1.5%30d +3.8%90d180d1y

Footnotes in full

F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2: The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.